2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester has been researched along with Disease Models, Animal in 1 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mete, A | 1 |
| Bowers, K | 1 |
| Bull, RJ | 1 |
| Coope, H | 1 |
| Donald, DK | 1 |
| Escott, KJ | 1 |
| Ford, R | 1 |
| Grime, K | 1 |
| Mather, A | 1 |
| Ray, NC | 1 |
| Russell, V | 1 |
1 other study available for 2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester and Disease Models, Animal
| Article | Year |
|---|---|
The design of a novel series of muscarinic receptor antagonists leading to AZD8683, a potential inhaled treatment for COPD.
Topics: Administration, Inhalation; Animals; Bronchoconstriction; Cycloheptanes; Disease Models, Animal; Gui | 2013 |